Todd R. Nelson
Net Worth
Last updated:
What is Todd R. Nelson net worth?
The estimated net worth of Dr. Todd R. Nelson is at least $2,391,511 as of 4 May 2023. He owns shares worth $176,894 as insider, has earned $7,277 from insider trading and has received compensation worth at least $2,207,340 in Codex DNA, Inc..
What is the salary of Todd R. Nelson?
Dr. Todd R. Nelson salary is $735,780 per year as Pres, Chief Executive Officer & Director in Codex DNA, Inc..
How old is Todd R. Nelson?
Dr. Todd R. Nelson is 58 years old, born in 1967.
What stocks does Todd R. Nelson currently own?
As insider, Dr. Todd R. Nelson owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Codex DNA, Inc. (DNAY) | Pres, Chief Executive Officer & Director | 136,072 | $1.3 | $176,894 |
What does Codex DNA, Inc. do?
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.
Todd R. Nelson insider trading
Codex DNA, Inc.
Dr. Todd R. Nelson has made only one insider trade between 2022-2023, according to the Form 4 filled with the SEC. He sold 2,575 units of DNAY stock worth $7,277 on 4 May 2023.
As of 4 May 2023 he still owns at least 136,072 units of DNAY stock.
Codex DNA key executives
Codex DNA, Inc. executives and other stock owners filed with the SEC:
- Dr. Todd R. Nelson (58) Pres, Chief Executive Officer & Director
- Mr. Daniel G. Gibson (48) Chief Technology Officer